RAP 0.00% 20.5¢ resapp health limited

Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-147

  1. 272 Posts.
    lightbulb Created with Sketch. 52
    As a consumer product SleepCheck will be huge if it gets good word of mouth. Also FDA application should be painless as it will be class I with traditional 510k. ResAppDx numbers looking very disappointing though...Hopefully that doesn't tell the whole story.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.